Idiopathic Pulmonary Fibrosis Manufacturers, Suppliers & Companies
-
Manufacturerbased in Denver, COLORADO (USA)
Eleven P15 creates Next Generation Diagnostics and Treatment for Pulmonary Fibrosis. The company focuses on the development of biomarkers that enable early detection of idiopathic pulmonary fibrosis and the discovery of genetically-targeted ...
Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, and localized to the lung. IPF is a fatal disease ...
CONTACT SUPPLIER -
Manufacturerbased in Austin, TEXAS (USA)
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing ...
Lung Therapeutics - Model LTI-03 - Revolutionary Compound for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive tissue scarring that prevents proper lung function. LTI-03 operates through a novel mechanism of action ...
CONTACT SUPPLIER -
Technologybased in Menlo Park, CALIFORNIA (USA)
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to ...
CohBar - Model CB5138-3 - Biotechnology for Idiopathic Pulmonary Fibrosis and Other Fibrotic Diseases
We are developing CB5138-3 to treat IPF and are evaluating the impact of CB5138 Analogs on a variety of other chronic fibrotic conditions. CB5138-3 has been shown to: Decrease expression of fibrosis biomarkers in co-cultures of lung ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
Model AZD5055 - Phase I - Idiopathic Pulmonary Fibrosis
Mechanism: Porcupine inhibitor. Area under investigation: idiopathic pulmonary fibrosis. Date commenced phase: Q4 2021. Estimated Filing Acceptance: Country US: EU: Japan: China. Additional ...
CONTACT SUPPLIER -
Technologybased in Bundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
Lungs - Idiopathic Pulmonary Fibrosis (IPF)
A specific form of lung fibrosis is Idiopathic pulmonary fibrosis (IPF), which is a chronic and ultimately fatal disease, where tissue deep in the lungs becomes scarred, over time, ...
CONTACT SUPPLIER -
Manufacturerbased in Bryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics
Idiopathic pulmonary fibrosis [IPF] is a form of progressive pulmonary fibrosis, or abnormal scarring of the lungs. As the disease progresses, the increased ...
CONTACT SUPPLIER -
Manufacturerbased in Montreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
-
Software vendorbased in San Mateo, CALIFORNIA (USA)
NuMedii has been pioneering the use of Big Data, Artificial Intelligence (AI) and systems biology since 2010 to accelerate the discovery of precision therapies to address high unmet medical needs. NuMedii has active R&D collaborations with several ...
-
Manufacturerbased in Southampton, UNITED KINGDOM
Synairgen is a drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on COVID-19, severe asthma and COPD, discovers and develops ...
-
Manufacturerbased in Providence, RHODE ISLAND (USA)
Ocean Biomedical is a 21st century biopharma company that partners with leading scientists and research institutions to accelerate the translation of new discoveries into breakthrough medicines. We're working to bring together the interdisciplinary ...
Therapeutic Antibodies for Effective Treatment of Non-Small Cell Lung Cancer
New therapeutic antibodies for effective treatment of NSCLC and other disorders. We are moving towards Phase 1 clinical trials of patented antibodies for the treatment of NSCLC. Our lead program, OCX-253 was chosen because it stimulates the B-Raf ...
CONTACT SUPPLIER -
Technologybased in Saint Kevin`s, IRELAND
At Horizon, we believe science and compassion must work together to transform lives. Our mission to deliver medicines for rare, autoimmune and severe inflammatory diseases and provide compassionate support comes from our strong and simple philosophy ...
Horizon - Model HZN-825 - Diffuse Cutaneous Systemic Sclerosis
A molecule that blocks lysophosphatidic acid receptor 1 (LPAR1). We are conducting a Phase 2b pivotal trial in diffuse cutaneous systemic sclerosis and a Phase 2b pivotal trial in idiopathic pulmonary ...
CONTACT SUPPLIER -
Manufacturerbased in Frenchs Forest, AUSTRALIA
Pharmaxis Ltd is an Australian clinical stage drug development company with expertise in developing drugs for inflammatory and fibrotic diseases and focussed on myelofibrosis. The company has a highly productive drug discovery engine, drug ...
Pharmaxis - Model PXS-5382 - LOXL2 Inhibitors for Multiple Indications
The LOXL2 enzyme is fundamental to the fibrotic cascade that follows chronic inflammation in kidney fibrosis, the liver disease NASH, cardiac fibrosis and idiopathic pulmonary ...
CONTACT SUPPLIER -
Manufacturerbased in Montreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
-
Manufacturerbased in Newcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
Human Lung Fibroblasts
and proliferation. Following injury, pulmonary fibroblasts proliferate playing an important role in the repair and remodelling of tissue. However, excessive proliferation of fibroblasts can result in abnormal tissue ...
CONTACT SUPPLIER -
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve care throughout the patient journey. We ask the right questions and provide answers that give physicians and patients a clearer ...
-
Consulting firmbased in Dublin, IRELAND
Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. We offer a full range of consulting, clinical development and commercialisation services from a global network of offices in ...
Respiratory Devices and Diagnostics Service
Focused on the unique needs of device and diagnostics manufacturers, ICON has broad experience in supporting trials of respiratory disease and infectious disease affecting respiratory function. The prevalence of respiratory diseases will continue to ...
CONTACT SUPPLIER -
Research institutebased in Bangkok, THAILAND
The Regeneration Center provides comprehensive and scientifically backed stem cell treatments for numerous conditions and degenerative diseases. Through years of research and clinical applications of modern cellular therapeutics our internationally ...
Placenta, Amniotic Membrane & Chorion Derived Stem Cells
Several clinical studies have clearly demonstrated the benefits of stem cells. Peer-reviewed medical journals today are intent on finding the richest source of stem cells in the human body. Researchers have found that umbilical cord blood is rich ...
CONTACT SUPPLIER -
Manufacturerbased in Silver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
TYVASO - Treprostinil Inhalation Solution
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you